title: Successful desensitization protocol for delayed cutaneous eruption to temozolomide.
authors.affiliation: Department of Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, Calif. Electronic address: eaclayton@mednet.ucla.edu.
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Clayton
authors.affiliation: Department of Pharmaceutical Services, Ronald Reagan UCLA Medical Center, Los Angeles, Calif.
authors.forename: Jason
authors.initials: J
authors.lastname: Madamba
authors.affiliation: Division of Neuro-oncology, Department of Neurology, Ronald Reagan UCLA Medical Center, Los Angeles, Calif.
authors.forename: Xiao-Tang
authors.initials: XT
authors.lastname: Kong
authors.affiliation: Division of Clinical Immunology and Allergy, Department of Medicine, Ronald Reagan UCLA Medical Center, Los Angeles, Calif.
authors.forename: Melinda
authors.initials: M
authors.lastname: Braskett
mesh_terms: D000328:Adult; D018906:Antineoplastic Agents, Alkylating / Q000009:adverse effects*; D003606:Dacarbazine / Q000009:adverse effects / Q000031:analogs & derivatives*; D003888:Desensitization, Immunologic; D003875:Drug Eruptions / Q000209:etiology / Q000628:therapy*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced / Q000628:therapy*; D006969:Hypersensitivity, Immediate / Q000139:chemically induced / Q000628:therapy*; D008297:Male; D000077204:Temozolomide
chemical_list: D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide